ASCO 2020: Maintenance Therapy with Avelumab Post-Chemo Improves Overall Survival of Bladder Cancer Patients
By Ruchi Jhonsa, Ph.D. Bladder cancer is the 6th most common cancer in the US and is responsible for 200,000 deaths globally in 2018. The current standard of care for …
Read More